EditorialOpen Access · CC BY 4.0
Editorial: Epigenetic modifications and cardiovascular diseases
Frontiers in Pharmacology · 14.05.2026 · 17
DOI: 10.3389/fphar.2026.1870690 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Pharmacology, online erschienen am 14.05.2026. Verfasst von Indira Pokkunuri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Sciences, University of Houston Downtown, Houston, TX, United States. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
DNA methylationcardiovascular diseasesepigeneticsextracellular vesiclesvascular remodeling
Autor:innen und Institutionen
- Department of Natural Sciences, University of Houston Downtown, Houston, TX, United States.
- Department of Biological Sciences, East Tennessee State University, Johnson City, TN, United States.
- Department of Biomedical Health Sciences, East Tennessee State University, Johnson City, TN, United States.
Zitieren
APA
Pokkunuri, I., Foster, C. R., & Dalal, S. (2026). Editorial: Epigenetic modifications and cardiovascular diseases. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1870690
Vancouver
Pokkunuri I, Foster CR, Dalal S. Editorial: Epigenetic modifications and cardiovascular diseases. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1870690
BibTeX
@article{Pokkunuri2026,
author = {Pokkunuri, Indira and Foster, Cerrone R and Dalal, Suman},
title = {Editorial: Epigenetic modifications and cardiovascular diseases},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1870690}
}
EUVIMED